This study aims to evaluate the safety and efficacy of osimertinib (AZD9291) among patients with non-small cell lung cancer with EGFR exon 20 insertions.
Contact phone
(517) 364-2835
Contact email
[email protected]
Principal investigator
Dr. Srkalovic, MD, PhD
Trial Category
Cancer
Trial SubCategory
Lung
Webform